Announcement
GENERAL: FPH: FPH Updates Release Date for Full Year Results
08:31am
FPH
06/04/2020 08:31
GENERAL
NOT PRICE SENSITIVE
REL: 0831 HRS Fisher & Paykel Healthcare Corporation Limited
GENERAL: FPH: FPH Updates Release Date for Full Year Results
Stock Exchange Announcement
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)
Fisher & Paykel Healthcare updates release date for full year results
Auckland, New Zealand, 6 April 2020 - Fisher & Paykel Healthcare Corporation
Limited advises that the company's results for the year ended 31 March 2020
will be released on Monday,
29 June 2020, instead of Thursday, 28 May 2020, as previously advised.
This announcement has been made in reliance on the NZX class waiver dated 19
March 2020, which provides listed companies with an additional 30 days to
prepare and release their full year results, and an additional two months to
prepare and deliver their annual reports.
Fisher & Paykel Healthcare Corporation Limited intends to release its annual
report together with its financial results on Monday, 29 June 2020 and,
accordingly, as at the date of this announcement, does not intend to rely on
the NZX class waiver with respect to the publication of its annual report.
"At the present time, we have nearly 5,000 people around the world who are
focussed on meeting the increased demand for our respiratory products, which
are being used in the treatment of patients with COVID-19," said Chief
Financial Officer Lyndal York.
"This time of year our financial controllers in our global offices would
usually be dedicated to completing year end reporting. Because of the
COVID-19 pandemic, many of these people are currently working remotely -
assisting with customer enquiries, getting product into the hands of
customers and providing operational support."
"One of our core beliefs is doing what is best for the patient, and it should
come as no surprise that we think that these activities should take
priority," said Mrs York.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer
of products and systems for use in respiratory care, acute care, surgery and
the treatment of obstructive sleep apnea. The company's products are sold in
over 120 countries worldwide. For more information about the company, visit
our website www.fphcare.com.
Ends
Media & Investor Contacts:
Karen Knott
Senior Communications Manager
karen.knott@fphcare.co.nz
+64 (0) 21 713 911
Hayden Brown
Investor Relations Manager
hayden.brown@fphcare.co.nz
+64 (0) 27 807 8073
Authorised by:
Lyndal York
Chief Financial Officer.
End CA:00351285 For:FPH Type:GENERAL Time:2020-04-06 08:31:40
Click here
to view related attachments.
